[210128 저널발표] Familial Alzheimer's disease mutations in PSEN1 lead to premature human stem cell neurogenesis
김지은 │ 2021-01-27
. 2021 Jan 12;34(2):108615.
Familial Alzheimer's Disease Mutations in PSEN1 Lead to Premature Human Stem Cell Neurogenesis
Mutations in presenilin 1 (PSEN1) or presenilin 2 (PSEN2), the catalytic subunit of γ-secretase, cause familial Alzheimer's disease (fAD). We hypothesized that mutations in PSEN1 reduce Notch signaling and alter neurogenesis. Expression data from developmental and adult neurogenesis show relative enrichment of Notch and γ-secretase expression in stem cells, whereas expression of APP and β-secretase is enriched in neurons. We observe premature neurogenesis in fAD iPSCs harboring PSEN1 mutations using two orthogonal systems: cortical differentiation in 2D and cerebral organoid generation in 3D. This is partly driven by reduced Notch signaling. We extend these studies to adult hippocampal neurogenesis in mutation-confirmed postmortem tissue. fAD cases show mutation-specific effects and a trend toward reduced abundance of newborn neurons, supporting a premature aging phenotype. Altogether, these results support altered neurogenesis as a result of fAD mutations and suggest that neural stem cell biology is affected in aging and disease.
Keywords: Alzheimer’s disease; NOTCH; PSEN1; hippocampus; iPSC; neurogenesis; organoid; γ-secretase.
|Prev||[210128 저널발표] Norepinephrine metabolite DOPEGAL activates AEP and pathologi...|
|Next||[210205 저널발표] Restoring metabolism of myeloid cells reverses cognitive decli...|